Aurobindo Pharma Archives - Page 2 of 11 - Express Pharma

Aurobindo units recall products in US market for manufacturing issues

Aurobindo Pharma subsidiary’s plant gets one observation from US FDA

Aurobindo Pharma’s Andhra unit gets three US FDA observations

Building secure, resilient, next-gen supply chains

Aurobindo Pharma receives Sebi’s warning letter over ongoing US FDA audit

Green packaging: A huge responsibility

Aurobindo Pharma Q4 net profit falls 28 per cent; revenue dips three per cent

Aurobindo Pharma gets US FDA nod for generic cancer drug Bortezomib

Aurobindo and Sun Pharma recall products in US market

Aurobindo Pharma acquires domestic formulations business of Veritaz Healthcare